E-LIB Suche - Ergebnisse für: Erman, Mustafa

1

A randomized, open-label, phase 3 trial of pembrolizumab pl..:

Lara Jr, Primo N. ; Villanueva, Luis ; Ibanez, Carolina...
BMC Cancer. 23 (2024) S1 - p. , 2024

Link: https://doi.org/10.1186/..

2

Impact of opioid analgesics on survival in cancer patients ..:

Kavgaci, Gozde ; Guven, Deniz Can ; Kaygusuz, Yunus...
Supportive Care in Cancer. 32 (2024) 7 - p. , 2024

Link: https://doi.org/10.1007/..

3

Objective response rate is a surrogate marker for long-term..:

Tural, Deniz ; Arslan, Cagatay ; Selcukbiricik, Fatih...
Clinical Genitourinary Cancer. , 2024

Link: https://doi.org/10.1016/..

4

Efficacy of Systemic Treatments in Patients With Metastatic..:

Demir, Tarık ; Araz, Murat ; Moloney, Carolyn...
Clinical Lung Cancer. , 2024

Link: https://doi.org/10.1016/..

5

Mean Platelet Volume to Lymphocyte Ratio: A New Biomarker P..:

Yildirim, Hasan Cagri ; Kus, Fatih ; Guven, Deniz Can...
Journal of Immunotherapy and Precision Oncology. 6 (2023) 4 - p. 170-176 , 2023

Link: https://doi.org/10.36401..

6

NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremel..:

de Castro Jr., Gilberto ; Rizvi, Naiyer A. ; Schmid, Peter...
Journal of Thoracic Oncology. 18 (2023) 1 - p. 106-119 , 2023

Link: https://doi.org/10.1016/..

7

Is there any prognostic significance in pleural involvement..:

Güner, Gürkan ; Aktaş, Burak Yasin ; Başal, Fatma Buğdaycı...
Journal of Cancer Research and Clinical Oncology. 149 (2023) 14 - p. 13271-13277 , 2023

Link: https://doi.org/10.1007/..

8

Prognostic factors of overall and prostate‐specific antigen..:

Telli, Tugce ; Tuncel, Murat ; Karabulut, Erdem...
The Prostate. 83 (2023) 8 - p. 792-800 , 2023

Link: https://doi.org/10.1002/..

9

PP.02 Tyrosine Kinase Inhibitor (TKI) Real-World Use in Epi..:

Minatta, Jose ; Samol, Jens ; Moiseenko, Fedor...
Journal of Thoracic Oncology. 18 (2023) 3 - p. S9 , 2023

Link: https://doi.org/10.1016/..

10

Five-Year Outcome and Safety in Patients Treated With Immun..:

Tural, Deniz ; Arslan, Cagatay ; Selcukbiricik, Fatih...
Clinical Genitourinary Cancer. 21 (2023) 3 - p. 334-341 , 2023

Link: https://doi.org/10.1016/..

11

The efficacy of immunotherapy and chemoimmunotherapy in pat..:

Guven, Deniz Can ; Aykan, Musa Baris ; Muglu, Harun...
Cancer Medicine. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1002/..

12

Immunogenicity of two doses of inactive COVID‐19 vaccine an..:

Guven, Deniz Can ; Incesu, Fatma Gul Gulbahce ; Yildirim, Hasan Cagri...
International Journal of Cancer. 152 (2022) 4 - p. 679-685 , 2022

Link: https://doi.org/10.1002/..

13

The benefit of treatment beyond progression with immune che..:

Guven, Deniz Can ; Yekeduz, Emre ; Erul, Enes...
Journal of Cancer Research and Clinical Oncology. 149 (2022) 7 - p. 3599-3606 , 2022

Link: https://doi.org/10.1007/..

14

The Association between Early Changes in Neutrophil-Lymphoc..:

Guven, Deniz Can ; Sahin, Taha Koray ; Erul, Enes...
Journal of Clinical Medicine. 11 (2022) 15 - p. 4523 , 2022

Link: https://doi.org/10.3390/..

15

Blood Based Biomarkers as Predictive Factors for Hyperprogr..:

Yildirim, Hasan Cagri ; Guven, Deniz Can ; Aktepe, Oktay Halit...
Journal of Clinical Medicine. 11 (2022) 17 - p. 5171 , 2022

Link: https://doi.org/10.3390/..